$82.4 Billion is the total value of TD ASSET MANAGEMENT INC's 1713 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CHT | CHUNGHWA TELECOM CO LTDspon adr new11 | $65,507,000 | +6.6% | 1,696,200 | 0.0% | 0.08% | -5.9% | |
NEEPRQ | NEXTERA ENERGY INCunit 99/99/9999 | $26,199,000 | +7.6% | 510,000 | 0.0% | 0.03% | -5.9% | |
GDX | VANECK VECTORS ETF TRgold miners etf | $17,164,000 | -8.0% | 476,500 | 0.0% | 0.02% | -19.2% | |
AU | ANGLOGOLD ASHANTI LIMITEDsponsored adr | $6,435,000 | -14.3% | 284,504 | 0.0% | 0.01% | -20.0% | |
PAE | PAE INC | $4,065,000 | +8.0% | 442,789 | 0.0% | 0.01% | 0.0% | |
KRTX | KARUNA THERAPEUTICS INC | $2,889,000 | +31.4% | 28,437 | 0.0% | 0.00% | +33.3% | |
NSCO | NESCO HLDGS INC | $3,392,000 | +77.6% | 460,257 | 0.0% | 0.00% | +33.3% | |
QTRX | QUANTERIX CORP | $2,557,000 | +37.8% | 54,979 | 0.0% | 0.00% | 0.0% | |
NRIX | NURIX THERAPEUTICS INC | $1,248,000 | -5.8% | 37,944 | 0.0% | 0.00% | 0.0% | |
PRLD | PRELUDE THERAPEUTICS INC | $1,611,000 | +137.6% | 22,509 | 0.0% | 0.00% | +100.0% | |
LSTR | LANDSTAR SYS INC | $1,419,000 | +7.3% | 10,535 | 0.0% | 0.00% | 0.0% | |
SDGR | SCHRODINGER INC | $1,339,000 | +66.7% | 16,909 | 0.0% | 0.00% | +100.0% | |
DRNA | DICERNA PHARMACEUTICALS INC | $1,451,000 | +22.4% | 65,880 | 0.0% | 0.00% | 0.0% | |
DCPH | DECIPHERA PHARMACEUTICALS IN | $1,251,000 | +11.3% | 21,919 | 0.0% | 0.00% | 0.0% | |
CNST | CONSTELLATION PHARMCETICLS I | $444,000 | +42.3% | 15,400 | 0.0% | 0.00% | – | |
CMLFU | CM LIFE SCIENCES INCunit 09/01/2025 | $607,000 | +10.8% | 52,327 | 0.0% | 0.00% | 0.0% | |
TARA | PROTARA THERAPEUTICS INC | $610,000 | +43.9% | 25,185 | 0.0% | 0.00% | 0.0% | |
BNR | BURNING ROCK BIOTECH LTDsponsored ads | $972,000 | -8.0% | 42,093 | 0.0% | 0.00% | 0.0% | |
ARDX | ARDELYX INC | $578,000 | +23.2% | 89,278 | 0.0% | 0.00% | 0.0% | |
BTU | PEABODY ENGR CORP | $682,000 | +4.8% | 282,884 | 0.0% | 0.00% | 0.0% | |
AMRN | AMARIN CORP PLCspons adr new | $621,000 | +16.3% | 126,927 | 0.0% | 0.00% | 0.0% | |
NKTX | NKARTA INC | $1,093,000 | +104.7% | 17,776 | 0.0% | 0.00% | 0.0% | |
AKUS | AKOUOS INC | $657,000 | -13.3% | 33,154 | 0.0% | 0.00% | 0.0% | |
OBNK | ORIGIN BANCORP INC | $1,149,000 | +30.0% | 41,365 | 0.0% | 0.00% | 0.0% | |
PSTHWS | PERSHING SQUARE TONTINE HLDG*w exp 07/24/202 | $495,000 | +33.8% | 51,550 | 0.0% | 0.00% | 0.0% | |
LNTH | LANTHEUS HLDGS INC | $992,000 | +6.4% | 73,534 | 0.0% | 0.00% | 0.0% | |
KPTI | KARYOPHARM THERAPEUTICS INC | $450,000 | +5.9% | 29,087 | 0.0% | 0.00% | 0.0% | |
ISEE | IVERIC BIO INC | $824,000 | +22.6% | 119,177 | 0.0% | 0.00% | 0.0% | |
MDGL | MADRIGAL PHARMACEUTICALS INC | $534,000 | -6.3% | 4,800 | 0.0% | 0.00% | 0.0% | |
EBSB | MERIDIAN BANCORP INC MD | $1,194,000 | +44.0% | 80,098 | 0.0% | 0.00% | 0.0% | |
RLAY | RELAY THERAPEUTICS INC | $762,000 | -2.4% | 18,340 | 0.0% | 0.00% | 0.0% | |
RGNX | REGENXBIO INC | $840,000 | +64.7% | 18,520 | 0.0% | 0.00% | 0.0% | |
GTHX | G1 THERAPEUTICS INC | $519,000 | +55.9% | 28,842 | 0.0% | 0.00% | – | |
GWPH | GW PHARMACEUTICALS PLCads | $1,197,000 | +18.5% | 10,376 | 0.0% | 0.00% | 0.0% | |
RACA | THERAPEUTICS ACQUISITION COR | $687,000 | -3.0% | 49,262 | 0.0% | 0.00% | 0.0% | |
EPZM | EPIZYME INC | $493,000 | -8.9% | 45,374 | 0.0% | 0.00% | 0.0% | |
ENTA | ENANTA PHARMACEUTICALS INC | $974,000 | -8.1% | 23,147 | 0.0% | 0.00% | 0.0% | |
DYN | DYNE THERAPEUTICS INC | $579,000 | +3.9% | 27,586 | 0.0% | 0.00% | 0.0% | |
EPD | ENTERPRISE PRODS PARTNERS L | $219,000 | +23.7% | 11,202 | 0.0% | 0.00% | – | |
MIST | MILESTONE PHARMACEUTICALS IN | $155,000 | -8.3% | 23,065 | 0.0% | 0.00% | – | |
SBT | STERLING BANCORP INC | $266,000 | +51.1% | 58,512 | 0.0% | 0.00% | – | |
CARA | CARA THERAPEUTICS INC | $294,000 | +19.0% | 19,400 | 0.0% | 0.00% | – | |
BMYRT | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $156,000 | -69.3% | 225,742 | 0.0% | 0.00% | -100.0% | |
GSV | GOLD STD VENTURES CORP | $195,000 | -9.3% | 273,338 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- TD Waterhouse Private Investment Counsel Inc. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ROYAL BK CDA SUSTAINABL | 42 | Q3 2023 | 5.6% |
SPDR S&P 500 ETF TR | 42 | Q3 2023 | 7.8% |
TORONTO DOMINION BK ONT | 42 | Q3 2023 | 4.7% |
BANK N S HALIFAX | 42 | Q3 2023 | 5.2% |
BANK MONTREAL QUE | 42 | Q3 2023 | 3.6% |
CDN IMPERIAL BK OF COMMERCE | 42 | Q3 2023 | 4.0% |
MICROSOFT CORP | 42 | Q3 2023 | 5.2% |
ENBRIDGE INC | 42 | Q3 2023 | 2.8% |
CANADIAN NATL RY CO | 42 | Q3 2023 | 2.6% |
APPLE INC | 42 | Q3 2023 | 4.6% |
View TD ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
GENERAL AMERICAN INVESTORS CO INCSold out | February 09, 2023 | 0 | 0.0% |
HEXCEL CORP /DE/ | February 06, 2020 | 52,545 | 0.1% |
LGI Homes, Inc. | February 06, 2020 | 20,862 | 0.1% |
PETMED EXPRESS INCSold out | February 06, 2020 | 0 | 0.0% |
Pzena Investment Management, Inc.Sold out | February 06, 2020 | 0 | 0.0% |
SERVICEMASTER GLOBAL HOLDINGS INCSold out | February 06, 2020 | 0 | 0.0% |
HARMONIC INCSold out | February 08, 2019 | 0 | 0.0% |
PTC INC. | February 08, 2019 | 54,654 | 0.1% |
UNIVERSAL DISPLAY CORP \PA\ | February 08, 2019 | 36,114 | 0.1% |
CANADIAN IMPERIAL BANK OF COMMERCE /CAN/ | February 08, 2018 | 19,253,023 | 4.4% |
View TD ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
SC 13G/A | 2024-02-09 |
13F-HR | 2023-10-27 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-10 |
SC 13G/A | 2023-02-09 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-07 |
13F-HR | 2022-08-04 |
13F-HR | 2022-05-10 |
View TD ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.